Clinical Goals and Barriers to Effective Psoriasis Care

Bruce E. Strober, Joelle M. van der Walt, April W. Armstrong, Marc Bourcier, Andre V.E. Carvalho, Edgardo Chouela, Arnon D. Cohen, Claudia de la Cruz, Charles N. Ellis, Andrew Y. Finlay, Alice B. Gottlieb, Johann E. Gudjonsson, Lars Iversen, C. Elise Kleyn, Craig L. Leonardi, Charles W. Lynde, Caitriona Ryan, Colin T. Theng, Fernando Valenzuela, Ronald VenderJashin J. Wu, Helen S. Young, Alexa B. Kimball

    Research output: Contribution to journalComment/debate

    51 Scopus citations


    Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the treatment goals of psoriasis patients and worldwide barriers to optimal care. Setting clear expectations might ultimately encourage undertreated psoriasis patients to seek care in an era in which great gains in therapeutic efficacy have been achieved. Here, we discuss the option for early treatment of all categories of psoriasis to alleviate disease impact while emphasizing the need for more focused attention for psoriasis patients with mild and moderate forms of this autoimmune disease. In addition, we encourage policy changes to keep pace with the innovative therapies and clinical science and highlight the demand for greater understanding of treatment barriers in resource-poor countries.

    Original languageEnglish
    Pages (from-to)5-18
    Number of pages14
    JournalDermatology and Therapy
    Issue number1
    StatePublished - 1 Mar 2019


    • Body surface area
    • Clearance
    • Comorbidities
    • DLQI
    • Itch
    • PASI
    • Physician Global Assessment
    • Psoriasis

    ASJC Scopus subject areas

    • Dermatology


    Dive into the research topics of 'Clinical Goals and Barriers to Effective Psoriasis Care'. Together they form a unique fingerprint.

    Cite this